{"title":"Inhibition of quorum sensing related virulence factor production in Pseudomonas aeruginosa PAO1 by Naringenin.","authors":"Changquan Chen, Jinping Xiong, Meixin Wen, Fei Shi, Gang Ye, Ling Zhao, Wei Zhang, Fei Cao, Hongmei Yin, Yinglun Li, Huaqiao Tang","doi":"10.1093/lambio/ovaf041","DOIUrl":null,"url":null,"abstract":"<p><p>The P. aeruginosa, widely spread and highly detrimental nosocomial pathogen, exhibits extensive intrinsic and acquired antibiotics resistance. Naringenin, a flavonoid compound, exhibits diverse pharmacological activities, especially in inhibiting the growth of many pathogenic bacteria. Our study revealed that naringenin showed significant inhibition on the virulence factors of P. aeruginosa at non bactericidal concentrations. At the concentration of 200 μg·mL-1, naringenin inhibited the swarming and swimming motility of P. aeruginosa, reduced pyocyanin secretion, and flagella assembly. Quantitative real-time polymerase chain reaction experiment was conducted, and the results showed that naringenin could reduce the expression of bacterial virulence factors related to P. aeruginosa. Naringenin inhibited bacterial adherence capability to cells in vitro. The larvae of Galleria mellonella showed a higher survival rate in treatment with naringenin in vivo. These findings suggested a promising role of naringenin in suppressing the virulence of P. aeruginosa, which encompasses the growth inhibition of various pathogenic bacteria. This indicates substantial potential for future therapeutic interventions targeting bacterial virulence.</p>","PeriodicalId":17962,"journal":{"name":"Letters in Applied Microbiology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Letters in Applied Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/lambio/ovaf041","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The P. aeruginosa, widely spread and highly detrimental nosocomial pathogen, exhibits extensive intrinsic and acquired antibiotics resistance. Naringenin, a flavonoid compound, exhibits diverse pharmacological activities, especially in inhibiting the growth of many pathogenic bacteria. Our study revealed that naringenin showed significant inhibition on the virulence factors of P. aeruginosa at non bactericidal concentrations. At the concentration of 200 μg·mL-1, naringenin inhibited the swarming and swimming motility of P. aeruginosa, reduced pyocyanin secretion, and flagella assembly. Quantitative real-time polymerase chain reaction experiment was conducted, and the results showed that naringenin could reduce the expression of bacterial virulence factors related to P. aeruginosa. Naringenin inhibited bacterial adherence capability to cells in vitro. The larvae of Galleria mellonella showed a higher survival rate in treatment with naringenin in vivo. These findings suggested a promising role of naringenin in suppressing the virulence of P. aeruginosa, which encompasses the growth inhibition of various pathogenic bacteria. This indicates substantial potential for future therapeutic interventions targeting bacterial virulence.
期刊介绍:
Journal of & Letters in Applied Microbiology are two of the flagship research journals of the Society for Applied Microbiology (SfAM). For more than 75 years they have been publishing top quality research and reviews in the broad field of applied microbiology. The journals are provided to all SfAM members as well as having a global online readership totalling more than 500,000 downloads per year in more than 200 countries. Submitting authors can expect fast decision and publication times, averaging 33 days to first decision and 34 days from acceptance to online publication. There are no page charges.